92 related articles for article (PubMed ID: 8800057)
21. Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma.
Coltrera MD; Wang J; Porter PL; Gown AM
Cancer Res; 1995 Jun; 55(12):2703-8. PubMed ID: 7780988
[TBL] [Abstract][Full Text] [Related]
22. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
Bran B; Bran G; Hörmann K; Riedel F
Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
[TBL] [Abstract][Full Text] [Related]
23. Circulating markers in squamous cell carcinoma of the head and neck: a review.
Rassekh CH; Johnson JT; Eibling DE
Eur J Cancer B Oral Oncol; 1994 Jan; 30B(1):23-8. PubMed ID: 9135969
[TBL] [Abstract][Full Text] [Related]
24. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
Linkov F; Lisovich A; Yurkovetsky Z; Marrangoni A; Velikokhatnaya L; Nolen B; Winans M; Bigbee W; Siegfried J; Lokshin A; Ferris RL
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):102-7. PubMed ID: 17220337
[TBL] [Abstract][Full Text] [Related]
25. [Crystallization test in patients with head and neck neoplasms].
Kuczkowski J; Zaorski P; Betlejewski A
Otolaryngol Pol; 1995; 49 Suppl 20():121-4. PubMed ID: 9454116
[TBL] [Abstract][Full Text] [Related]
26. Serum biomarkers in head and neck squamous cell cancer.
Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
[TBL] [Abstract][Full Text] [Related]
27. Biomarkers predicting chemotherapy response in head and neck squamous cell carcinoma: a review.
Cosway B; Paleri V; Wilson J
J Laryngol Otol; 2015 Nov; 129(11):1046-52. PubMed ID: 26429303
[TBL] [Abstract][Full Text] [Related]
28. Serum samples should not be used to assess circulating matrix metalloproteinase-9 levels as a prognostic marker of disease.
Tanus-Santos JE; Gerlach RF
Int J Cancer; 2006 Feb; 118(3):789; author reply 790. PubMed ID: 16094623
[No Abstract] [Full Text] [Related]
29. Serum platelet-derived growth factor and fibroblast growth factor in patients with benign and malignant ovarian tumors.
Madsen CV; Steffensen KD; Olsen DA; Waldstrøm M; Søgaard CH; Brandslund I; Jakobsen A
Anticancer Res; 2012 Sep; 32(9):3817-25. PubMed ID: 22993324
[TBL] [Abstract][Full Text] [Related]
30. Tissue platelet derived-growth factor (PDGF) predicts for shortened survival and treatment failure in advanced breast cancer.
Seymour L; Dajee D; Bezwoda WR
Breast Cancer Res Treat; 1993; 26(3):247-52. PubMed ID: 8251649
[TBL] [Abstract][Full Text] [Related]
31. Prognostic implications of hemoglobin levels before and after surgery as well as before and after radiochemotherapy for head and neck tumors.
Reichel O; Panzer M; Wimmer C; Dühmke E; Kastenbauer E; Suckfüll M
Eur Arch Otorhinolaryngol; 2003 May; 260(5):248-53. PubMed ID: 12750913
[TBL] [Abstract][Full Text] [Related]
32. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.
Ozturk B; Coskun U; Sancak B; Yaman E; Buyukberber S; Benekli M
Int Immunopharmacol; 2009 May; 9(5):645-8. PubMed ID: 19249390
[TBL] [Abstract][Full Text] [Related]
33. A liquid biopsy for head and neck cancers.
Schmidt H; Kulasinghe A; Perry C; Nelson C; Punyadeera C
Expert Rev Mol Diagn; 2016; 16(2):165-72. PubMed ID: 26631411
[TBL] [Abstract][Full Text] [Related]
34. [Blood concentration of laminin gamma2 chain in patients with head and neck cancer].
Kuratomi Y; Katayama M; Kidera K; Hayashida S; Satoh S; Monji M; Shimazu R; Ayada T; Toh S; Inokuchi A
Nihon Jibiinkoka Gakkai Kaiho; 2006 Jun; 109(6):517-23. PubMed ID: 16838673
[TBL] [Abstract][Full Text] [Related]
35. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the total cfDNA and HPV16/18 detection in plasma samples of head and neck squamous cell carcinoma patients.
Mazurek AM; Rutkowski T; Fiszer-Kierzkowska A; Małusecka E; Składowski K
Oral Oncol; 2016 Mar; 54():36-41. PubMed ID: 26786940
[TBL] [Abstract][Full Text] [Related]
37. [Cytogenetic and hormonal changes in head and neck squamous cell cancer patients: potential biomarkers for functional approaches in surgical oncology].
Remenár E
Magy Onkol; 2009 Jun; 53(2):157-64. PubMed ID: 19581182
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of PDGF-AB and sP-selectin concentrations in relation to platelet count in patients with colorectal cancer before and after surgical treatment.
Mantur M; Koper O; Snarska J; Sidorska A; Kruszewska-Wnorowska K
Pol Arch Med Wewn; 2008 Jun; 118(6):345-50. PubMed ID: 18619189
[TBL] [Abstract][Full Text] [Related]
39. The role of platelet-derived growth factor production by tumor-associated macrophages in tumor stroma formation in lung cancer.
Vignaud JM; Marie B; Klein N; Plénat F; Pech M; Borrelly J; Martinet N; Duprez A; Martinet Y
Cancer Res; 1994 Oct; 54(20):5455-63. PubMed ID: 7923179
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
